NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
Press Release / April 18, 2025
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
Press Release / April 18, 2025
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
NS Pharma is thrilled to continue our journey with the #Duchenne community by sponsoring another @CureDuchenne Community Dinner.
📍 Location: True Foods, San Diego
🕒 Time: 6:00PM - 9:00PM PT
Secure your place at the table: https://ow.ly/lgxV50VFw1R
#CureDuchenneCares https://x.com/NSPharmaInc/status/1915767757037019295/photo/1
We’re thrilled to announce our sponsorship of the upcoming #JettFoundationFamilyWorkshop this Saturday in Iowa City!
This workshop is a fantastic opportunity to connect with specialists, share experiences, and gain insights that empower the #DuchenneCommunity.
See you there! https://x.com/NSPharmaInc/status/1915043616902234170/photo/1
We’re proud to share that the FDA has granted #OrphanDrug designation to NS-229 for the treatment of #EGPA — a rare autoimmune disease that affects fewer than 200,000 people in the U.S!
Check out the press release: https://ow.ly/zYkj50VEL8x
#RareDisease #FDA https://x.com/NSPharmaInc/status/1914333149225509365/photo/1
What is #Dystrophin? 🤔
It's a vital protein that plays a key role in supporting muscles as they contract and relax.
Without it, muscles become more prone to damage and gradually weaken, leading to mobility challenges.
Visit http://WeSpeakDuchenne.com to learn more! https://x.com/NSPharmaInc/status/1912869018521817581/photo/1
Are you ready to take the lead on something big?
We're looking for a dynamic leader to join us as our Executive Senior Director of Regulatory Affairs!
Think you've got the experience and the drive? Apply here: https://ow.ly/euPT50VB1aN
#PharmaJobs #Careers #Hiring https://x.com/NSPharmaInc/status/1912182937035977059/photo/1
We’re thrilled to welcome Tanya as our new Director of Supply Chain!
With 20+ years of experience in pharma, she brings a wealth of expertise in leading and shaping global clinical and commercial #SupplyChain operations.
#Welcome to the team!
#NewHire #GrowingTeam https://x.com/NSPharmaInc/status/1910694667563258037/photo/1
🌍 Celebrating #WorldHealthDay 🌍
At NS Pharma, we’re dedicated to advancing treatments and improving outcomes for those living with #RareDiseases—because every patient deserves the chance to thrive!
Shout-out to the researchers and HCPs working tirelessly to drive progress! https://x.com/NSPharmaInc/status/1909245458192474168/photo/1
